Testing effectiveness (Phase 2)Looking for participantsNCT06852820
What this trial is testing
68Ga-PSMA-11 PET-directed Radioligand Therapy in Metastatic Hepatocellular Carcinoma (HCC)
Who this might be right for
Liver CancerHepatocellular CarcinomaMetastatic Liver Cancer
Melissa Lumish 10